🔎 Trials Near Me

Почетна › Рак орофаринкса › Kalifornija

Kliničke studije za Рак орофаринкса u državi Kalifornija

10 studija za Рак орофаринкса traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Tower Cancer Research Foundation, Beverly Hills
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
  • и још 4
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05136196

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Oncura Health, Glendale
  • UC San Diego Health - Moores Cancer Center, La Jolla
  • California Research Institute, Los Angeles
  • и још 4
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07156227

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

  • City of Hope Medical Center, Duarte
  • Los Angeles Cancer Network (LACN), Los Angeles
  • Medical Oncology Associates of San Diego, San Diego
  • и још 1
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06295731

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • и још 3
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07195734

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Los Angeles Westwood Cancer Center, Los Angeles
  • Stanford Medicine - Cancer Center, Palo Alto
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07768189

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

  • Stanford University, Palo Alto
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT05880797

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • UC San Diego Health System - Encinitas, Encinitas
  • UC San Diego Moores Cancer Center, La Jolla
  • UC San Diego Medical Center - Hillcrest, San Diego
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06532279

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

  • Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills
  • Cedars Sinai Medical Center, Los Angeles
  • CS Cancer at Valley Oncology Medical Group, Tarzana
  • и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT06445114

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

  • City of Hope Corona, Corona
  • City of Hope Comprehensive Cancer Center, Duarte
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT05451004

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.